메뉴 건너뛰기
Digestive Diseases
Volumn 19, Issue 4, 2001, Pages 311-323
Systemic treatment of hepatocellular carcinoma
Author keywords

Chemotherapy; Hepatocellular carcinoma; Interferon; Octreotide; Systemic treatment
Indexed keywords

ALPHA INTERFERON; ANTHRACYCLINE; CISPLATIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; INTERLEUKIN 2; IODINATED POPPYSEED OIL; IRINOTECAN; MEGESTROL; MELATONIN; MITOMYCIN; NOLATREXED; OCTREOTIDE; PACLITAXEL; RETINOIC ACID; SOMATOSTATIN; STATIN; TAMOXIFEN; TEGAFUR;
EID: 0035729049     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050698     Document Type: Review
Times cited : (31)
References (69)
  • 1
    • 0033854015 scopus 로고    scopus 로고
    • Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor: A prospective randomized study of hepatitis C virus-related liver cancer
    • (2000) Hepatology , vol.32 , pp. 228
    • Ikeda, K.1    Arase, Y.2    Saitoh, S.3
  • 2
    • 0035872948 scopus 로고    scopus 로고
    • Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial
    • (2001) Ann Intern Med , vol.134 , pp. 963-967
    • Kubo, S.1    Nishiguchi, S.2    Hirohashi, K.3
  • 4
    • 5844370499 scopus 로고    scopus 로고
    • Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma
    • Hepatoma Prevention Study Group
    • (1996) N Engl J Med , vol.334 , pp. 1561-1567
    • Muto, Y.1    Moriwaki, H.2    Ninomiya, M.3
  • 5
    • 0033528522 scopus 로고    scopus 로고
    • Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial
    • (1999) Lancet , vol.353 , pp. 797
    • Lau, W.Y.1    Leung, T.W.2    Ho, S.K.3
  • 8
    • 0024805819 scopus 로고
    • Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: A prospective randomised trial
    • (1989) Br J Cancer , vol.60 , pp. 928-933
    • Lai, C.L.1    Wu, P.C.2    Lok, A.S.F.3
  • 11
    • 0342314475 scopus 로고    scopus 로고
    • Combined therapy consisting of intra-arterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis
    • (2000) Cancer , vol.88 , pp. 1986-1991
    • Chung, Y.H.1    Song, I.H.2    Song, B.C.3
  • 15
    • 0028109611 scopus 로고
    • Treatment of unresectable hepatocellular carcinoma with a combination of human recombinant alpha-2b interferon and doxorubicin: Results of a pilot study
    • (1994) Eur J Cancer , vol.30 A , pp. 1319-1325
    • Lotz, J.P.1    Grange, J.D.2    Hannoun, L.3
  • 18
    • 0032482661 scopus 로고    scopus 로고
    • Tamoxifen in treatment of hepatocellular carcinoma: A randomised controlled trial
    • (1998) Lancet , vol.352 , pp. 17-20
  • 21
    • 0033988010 scopus 로고    scopus 로고
    • Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: A prospective randomized study
    • (2000) Am J Gastroenterol , vol.95 , pp. 218-222
    • Liu, C.L.1    Fan, S.T.2    Ng, I.O.3
  • 38
    • 0028800995 scopus 로고
    • 5-Fluorouracil and d,l-leucovorin calcium are active to treat unresectable hepatocellular carcinoma patients: Preliminary results of a phase II study
    • (1995) Oncology , vol.52 , pp. 487-491
    • Porta, C.1    Moroni, M.2    Nastasi, G.3
  • 39
    • 0032994009 scopus 로고    scopus 로고
    • 5-Fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: Results of a phase II multicenter study of the Southern Italy Oncology Group (GOIM)
    • (1999) Anticancer Res , vol.19 , pp. 1407-1410
    • Gebbia, V.1    Maiello, E.2    Serravezza, G.3
  • 41
    • 0026577549 scopus 로고
    • Clinical efficacy and toxicity of standard dose Adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: Relation to liver tests and pharmacokinetic parameters
    • (1992) Br J Cancer , vol.65 , pp. 751-755
    • Johnson, P.J.1    Dobbs, N.2    Kalayci, C.3
  • 56
    • 0035134510 scopus 로고    scopus 로고
    • Preoperative systemic chemoimmunotherapy and sequential resection for unresectable hepatocellular carcinoma
    • (2001) Ann Surg , vol.233 , pp. 236-241
    • Lau, W.Y.1    Leung, T.W.2    Lai, B.S.3
  • 59
    • 0031833069 scopus 로고    scopus 로고
    • Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: Analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center
    • (1998) Cancer J Sci Am , vol.4 , pp. 178-184
    • Abrams, R.A.1    Pajak, T.F.2    Haulk, T.L.3
  • 63
    • 0028219170 scopus 로고
    • Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinoma
    • (1994) Eur J Cancer , vol.30 A , pp. 167-170
    • Aldeghi, R.1    Lissoni, P.2    Barni, S.3
  • 69
    • 0001659008 scopus 로고
    • Treatment with tamoxifen in patients with advanced hepatocellular carcinoma. Results of a randomized placebo controlled trial
    • (1995) Hepatology , vol.22
    • Coll, S.1    Sola, R.2    Vila, M.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.